Cargando…
Gastrointestinal disorders in Parkinson’s disease and other Lewy body diseases
Parkinson’s disease (PD) is pathologically characterized by the abnormal accumulation of α-synuclein fibrils (Lewy bodies) in the substantia nigra and other brain regions, although the role of Lewy bodies remains elusive. Constipation usually precedes the motor symptoms in PD, which is in accordance...
Autores principales: | Hirayama, Masaaki, Nishiwaki, Hiroshi, Hamaguchi, Tomonari, Ohno, Kinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160728/ https://www.ncbi.nlm.nih.gov/pubmed/37147392 http://dx.doi.org/10.1038/s41531-023-00511-2 |
Ejemplares similares
-
Gut microbiota in dementia with Lewy bodies
por: Nishiwaki, Hiroshi, et al.
Publicado: (2022) -
Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson’s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder
por: Nishiwaki, Hiroshi, et al.
Publicado: (2020) -
Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson’s disease
por: Nishiwaki, Hiroshi, et al.
Publicado: (2022) -
Intestinal Collinsella may mitigate infection and exacerbation of COVID-19 by producing ursodeoxycholate
por: Hirayama, Masaaki, et al.
Publicado: (2021) -
Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson's disease
por: Suzuki, Anzu, et al.
Publicado: (2018)